Wang et al. demonstrated that the P-gp levels were diminished by suppression of NF-κB through Bortezomib in leukemia cells resistant to Daunorubicin, a chemotherapeutic drug having similar effects like Dox58. This evidence concerns the gene NFKB1 and leukemia.